HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1700987Generated: October 31, 2026
Ethylmorpholine → (2R, 5E)-2-[(4S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl]-N-[(1S)-2,2-dimethyl-1-({[(1R)-1-phenylethyl]amino}carbonyl)propyl]-5-(3-fluoro-4-phenoxyphenyl)pent-4-enamide
https://huagongshe.com/reaction/1700987
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethylmorpholine | HCID 7525 | — |
| Reactant | Tri-o-tolylphosphine | HCID 80271 | — |
| Reactant | 4-Bromo-2-fluoro-1-phenoxybenzene | HCID 22736316 | — |
| Reactant | (2R)-2-[(4S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl]-N-[(1S)-2,2-dimethyl-1-({[(1R)-1-phenylethyl]amino}carbonyl)propyl]pent-4-enamide | HCID 57042918 | — |
| Catalyst | palladium(II) acetate | HCID 167845 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Product | (2R, 5E)-2-[(4S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl]-N-[(1S)-2,2-dimethyl-1-({[(1R)-1-phenylethyl]amino}carbonyl)propyl]-5-(3-fluoro-4-phenoxyphenyl)pent-4-enamide | HCID 59875800 | 22.7% |
Reaction Steps
A mixture of palladium acetate (17 mg, 0.075 mmol) and tri-(2-methylphenyl)phosphine (46 mg, 0.15 mmol) in anhydrous acetonitrile (2 mL) was sonicated at room temperature for 1 min until a creamy-coloured suspension formed. This suspension was added via Pasteur pipette to a stirred solution of (2R)-2-[(4S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl]-N-[(1S)-2,2-dimethyl-1-({[(1R)-1-phenylethyl]amino}carbonyl)propyl]pent-4-enamide (650 mg, 1.5 mmol), 1-bromo-3-fluoro-4-phenoxybenzene (Preparation 10)(587 mg, 2.26 mmol), and N-ethylmorpholine (348 μL, 3.0 mmol) in anhydrous acetonitrile (2.5 mL) under nitrogen. The mixture was purged with nitrogen, then heated at reflux for 16 h. After being cooled, the mixture was poured into ethyl acetate (100 mL) and washed with 5% aqueous citric acid (30 mL), saturated aqueous sodium chloride (50 mL), dried (NaSO4), and concentrated under reduced pressure. The residue was purified by flash chromatography (gradient elution with dichloromethane:ether) to give mainly (2R, 5E)-2-[(4S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl]-N-[(1S)-2,2-dimethyl-1-({[(1R)-1-phenylethyl]amino}carbonyl)propyl]-5-(3-fluoro-4-phenoxyphenyl)pent-4-enamide as a pale yellow foam (210 mg, 22%). 1H nmr suggested that alkene isomers were also present. The mixture of alkenes was taken onto the next step (see b, below).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06350907B1 |
|---|
| Source dataset | uspto-grants-2002_02 |
|---|
| ORD ID | ord-a5347c3f957541cf8803a97585d0dca6 |
|---|
| Source note | uspto-grants-2002_02 |
|---|